文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

血必净注射液对脓毒症大鼠肠道菌群及代谢物谱的正面影响

[Positive effects of Xuebijing injection on intestinal microbiota and metabolite spectrum in septic rats].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论脓毒症大鼠模型腹腔注射血必净4 mL/kg可降低24小时死亡率(47% vs 60%,P>0.05),改善肠道菌群失调并调节代谢物谱。

研究将45只雄性SD大鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症组和血必净组(CLP后1小时腹腔注射血必净4 mL/kg),每组15只。术后24小时观察生存并采集粪便行16S rRNA基因测序和液相色谱-质谱(LC-MS)分析。血必净组死亡率47%(7/15)低于CLP组60%(9/15),差异无统计学意义(P>0.05);血必净改善了脓毒症所致肠道菌群变化,α多样性呈升高趋势(Ace指数406.0±22.5 vs 363.2±38.2,Chao1指数409.7±21.8 vs 362.4±42.5,均P>0.05)。三组间有12种主要差异代谢物,与氨基酸和脂质代谢相关,代谢物变化与微生物群落显著相关。

要点

  • 脓毒症大鼠CLP后1小时腹腔注射血必净4 mL/kg,24小时死亡率47%(7/15)低于CLP组60%(9/15),P>0.05。
  • CLP组肠道菌群以拟杆菌门为主,假手术组和血必净组以厚壁菌门为主。
  • 血必净增加脓毒症大鼠有益菌丰度,如疣微菌门、阿克曼菌和乳杆菌。
  • 血必净组α多样性呈升高趋势(Ace指数406.0±22.5 vs 363.2±38.2,Chao1指数409.7±21.8 vs 362.4±42.5,均P>0.05)。
  • 三组间12种主要差异代谢物与氨基酸和脂质代谢相关,且与微生物群落变化显著相关。

适用人群与场景

  • 雄性Sprague-Dawley(SD)大鼠,CLP诱导的脓毒症模型;假手术组仅行开腹和盲肠游离未结扎穿孔。

诊断标准与关键阈值

  • 脓毒症模型采用盲肠结扎穿孔(CLP)法。

处置流程与药物剂量

  • 血必净组于CLP后1小时腹腔注射血必净注射液4 mL/kg。

研究设计与关键结果

  • 研究类型:动物实验;45只雄性SD大鼠随机分为假手术组、CLP组和血必净组,每组15只。
  • 24小时死亡率:血必净组47%(7/15)vs CLP组60%(9/15),P>0.05;假手术组全部存活。
  • α多样性呈升高趋势:Ace指数血必净组406.0±22.5 vs CLP组363.2±38.2,Chao1指数血必净组409.7±21.8 vs CLP组362.4±42.5,均P>0.05。
  • 菌群组成:CLP组以拟杆菌门为主,假手术组和血必净组以厚壁菌门为主;血必净增加疣微菌门、阿克曼菌和乳杆菌等有益菌丰度。
  • 代谢组:LC-MS和正交偏最小二乘判别分析(OPLS-DA)显示三组间有12种主要差异代谢物,与氨基酸和脂质代谢相关,代谢物变化与微生物群落显著相关。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠CLP脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血必净可改善脓毒症大鼠生存率、调节肠道菌群组成及相关代谢物,为血必净治疗脓毒症提供了新的病理生理机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the effect of Xuebijing injection on inflammation in sepsis by regulating intestinal microbiota and its metabolites.

METHODS: A total of 45 male Sprague-Dawley (SD) rats were randomly divided into Sham operation group (Sham group), cecal ligation and perforation (CLP) induced sepsis group (CLP group), and Xuebijing intervention group (XBJ group, 4 mL/kg Xuebijing injection was injected intraperitoneally at 1 hour after CLP), with 15 rats in each group. The survival of rats was observed at 24 hours after operation and sacrificed. Feces were collected for 16S rRNA gene sequencing and liquid chromatography-mass spectrometry (LC-MS) analysis.

RESULTS: At 24 hours after operation, all rats in the Sham group survived, the mortality of rats in the XBJ group was lower than that in the CLP group [47% (7/15) vs. 60% (9/15), P > 0.05]. Compared with the Sham group, the diversity of gut microbiota in the CLP group decreased, the dominant flora changed, and the abundance of inflammation-related flora increased. Xuebijing improved the changes in gut microbiota caused by sepsis, and α diversity showed an increasing trend (Ace index: 406.0±22.5 vs. 363.2±38.2, Chao1 index: 409.7±21.8 vs. 362.4±42.5, both P > 0.05). Restrictive constrained principal coordinate analysis (cPCoA) showed a high similarity in gut microbiota among the same group of rats. The CLP group was dominated by Bacteroidetes, while the Sham and XBJ groups were dominated by Firmicutes. In addition, compared with the CLP group, Xuebijing treatment increased the abundance of beneficial bacteria in septic rats, such as Verrucomicrobia, Akkermansia and Lactobacillus. LC-MS and orthogonal partial least squares discriminant analysis (OPLS-DA) showed that there were 12 main differential metabolites among the three groups, and there were certain correlations between these metabolites, which were related to amino acid and lipid metabolism. Correlation analysis showed a significant correlation between changes in metabolites and microbial communities.

CONCLUSIONS: Xuebijing can improve the survival rate of septic rats, regulate the composition of intestinal flora and related metabolites, which provides a new pathophysiological mechanism for Xuebijing in the treatment of sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ding X, Yuan Y, Tong R, et al. [Positive effects of Xuebijing injection on intestinal microbiota and metabolite spectrum in septic rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37545444. doi:10.3760/cma.j.cn121430-20230222-00104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。